[Analysis of 10 cases of brentuximab vedotin combined with chemotherapy in the treatment of children with refractory and or relapsed classic Hodgkin lymphoma].

MLA

Li, N., et al. “[Analysis of 10 Cases of Brentuximab Vedotin Combined with Chemotherapy in the Treatment of Children with Refractory and or Relapsed Classic Hodgkin Lymphoma].” Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, vol. 62, no. 8, Aug. 2024, pp. 775–79. EBSCOhost, https://doi.org/10.3760/cma.j.cn112140-20240615-00399.

APA

Li, N., Li, Y., Zhou, C. J., Huang, S., Jin, L., Yang, J., Shao, M. M., Sun, H., Wang, X. L., & Duan, Y. L. (2024). [Analysis of 10 cases of brentuximab vedotin combined with chemotherapy in the treatment of children with refractory and or relapsed classic Hodgkin lymphoma]. Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 62(8), 775–779. https://doi.org/10.3760/cma.j.cn112140-20240615-00399

Chicago

Li, N, Y Li, C J Zhou, S Huang, L Jin, J Yang, M M Shao, H Sun, X L Wang, and Y L Duan. 2024. “[Analysis of 10 Cases of Brentuximab Vedotin Combined with Chemotherapy in the Treatment of Children with Refractory and or Relapsed Classic Hodgkin Lymphoma].” Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics 62 (8): 775–79. doi:10.3760/cma.j.cn112140-20240615-00399.